Do 5-alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?
作者信息
Welk Blayne, Reid Jennifer, Ordon Michael, Campbell Jeffrey, Dixon Stephanie
机构信息
Division of Urology, Department of Surgery, Western University, London, ON, Canada.
ICES, Western University, London, ON, Canada.
出版信息
Can Urol Assoc J. 2021 Jun;15(6):214-216. doi: 10.5489/cuaj.7135.
Abstract
摘要
相似文献
1
Do 5-alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?5α还原酶抑制剂能否降低经尿道前列腺切除术后患者复发性肉眼血尿的风险？
Can Urol Assoc J. 2021 Jun;15(6):214-216. doi: 10.5489/cuaj.7135.
2
3
[Clinic analysis of repeat prostatectomy after transurethral prostatectomy for benign prostatic hyperplasia].经尿道前列腺电切术治疗良性前列腺增生后再次前列腺切除术的临床分析
Zhonghua Yi Xue Za Zhi. 2004 Mar 2;84(5):372-4.
4
Angioemboliziation of Internal Pudendal Artery for Treatment of Long Lasting Gross Hematuria After Transurethral Resection of the Prostate.经皮穿刺阴部内动脉栓塞术治疗前列腺电切术后长期严重血尿
Urol J. 2019 Oct 21;16(5):517-518. doi: 10.22037/uj.v0i0.4657.
5
Risk factors for delayed hematuria following photoselective vaporization of the prostate.前列腺绿激光汽化术后血尿延迟的危险因素。
J Urol. 2013 Sep;190(3):903-8. doi: 10.1016/j.juro.2013.03.070. Epub 2013 Mar 26.
6
Role of finasteride in the treatment of recurrent hematuria secondary to benign prostatic hyperplasia.非那雄胺在治疗良性前列腺增生继发复发性血尿中的作用。
Prostate. 1997 May 15;31(3):180-2. doi: 10.1002/(sici)1097-0045(19970515)31:3<180::aid-pros6>3.0.co;2-p.
7
[Transurethral treatment of massive hematuria post retropubic adenomectomy].[耻骨后前列腺腺瘤切除术后大量血尿的经尿道治疗]
Actas Urol Esp. 2007 Jul-Aug;31(7):743-5. doi: 10.1016/s0210-4806(07)73715-4.
8
Safety of transurethral surgery in the early postoperative period following an open cardiac procedure.心脏直视手术后早期经尿道手术的安全性。
J Urol. 1994 Apr;151(4):902-4. doi: 10.1016/s0022-5347(17)35118-2.
9
The treatment of gross hematuria secondary to prostatic bleeding with finasteride.非那雄胺治疗前列腺出血继发的肉眼血尿
J Urol. 1998 Apr;159(4):1232-3.
10
Comparative Effectiveness of Transurethral Prostate Procedures at Enabling Urologic Medication Discontinuation: A Retrospective Analysis.经尿道前列腺手术在停用泌尿外科药物方面的比较效果：一项回顾性分析。
Urology. 2019 Dec;134:192-198. doi: 10.1016/j.urology.2019.07.039. Epub 2019 Sep 19.
引用本文的文献
1
Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery?经尿道前列腺切除术（TURP）后使用α受体阻滞剂的预测因素：术前尿动力学结果能否预测术后α受体阻滞剂的用药？
PLoS One. 2022 Sep 21;17(9):e0274399. doi: 10.1371/journal.pone.0274399. eCollection 2022.
本文引用的文献
1
An evaluation of the federal adverse events reporting system data on adverse effects of 5-alpha reductase inhibitors.对联邦不良事件报告系统中关于5-α还原酶抑制剂不良反应数据的评估。
World J Urol. 2021 Apr;39(4):1233-1239. doi: 10.1007/s00345-020-03314-9. Epub 2020 Jun 28.
2
Population-based assessment of re-treatment and healthcare utilisation after photoselective vaporisation of the prostate or electrosurgical transurethral resection of the prostate.基于人群的前列腺绿激光汽化术或经尿道前列腺电切术后再次治疗和医疗保健利用评估。
BJU Int. 2019 Dec;124(6):1047-1054. doi: 10.1111/bju.14891. Epub 2019 Aug 26.
3
The Utilization of Benign Prostatic Hyperplasia and Bladder-Related Medications After a Transurethral Prostatectomy.经尿道前列腺切除术（TURP）后良性前列腺增生和膀胱相关药物的应用。
Urology. 2019 Aug;130:126-131. doi: 10.1016/j.urology.2019.05.003. Epub 2019 May 23.
4
Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate.经尿道双极前列腺切除术及汽化术后继发性出血
Urol Ann. 2016 Oct-Dec;8(4):458-463. doi: 10.4103/0974-7796.192110.
5
Efficacy of 5α-reductase inhibitors for patients with large benign prostatic hyperplasia (>80 mL) after transurethral resection of the prostate.5α-还原酶抑制剂对经尿道前列腺切除术后大体积良性前列腺增生（>80 mL）患者的疗效。
Aging Male. 2015;18(4):238-43. doi: 10.3109/13685538.2015.1068750. Epub 2015 Jul 30.
6
Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.术前5α-还原酶抑制剂对良性前列腺增生症患者围手术期失血的影响：一项随机对照试验的荟萃分析
BMC Urol. 2015 Jun 2;15:47. doi: 10.1186/s12894-015-0043-4.
7
Risk factors for delayed hematuria following photoselective vaporization of the prostate.前列腺绿激光汽化术后血尿延迟的危险因素。
J Urol. 2013 Sep;190(3):903-8. doi: 10.1016/j.juro.2013.03.070. Epub 2013 Mar 26.
8
Competing risk regression models for epidemiologic data.用于流行病学数据的竞争风险回归模型。
Am J Epidemiol. 2009 Jul 15;170(2):244-56. doi: 10.1093/aje/kwp107. Epub 2009 Jun 3.
9
Coding accuracy of administrative drug claims in the Ontario Drug Benefit database.安大略省药物福利数据库中行政药物报销申请的编码准确性。
Can J Clin Pharmacol. 2003 Summer;10(2):67-71.
Zotero 插件